New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 25, 2014
09:17 EDTCHEChemed price target raised to $110 from $92 at Oppenheimer
Oppenheimer increased its price target on Chemed after the company reported higher than expected EPS. The firm keeps an Outperform rating.
News For CHE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
16:12 EDTCHEChemed expects FY14 ex-items EPS $6.00-$6.05, consensus $5.95
Subscribe for More Information
16:11 EDTCHEChemed reports Q3 adjusted EPS $1.48, consensus $1.51
Reports Q3 revenue $358.4M, consensus $359.88M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use